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We defined the positive predictive accuracy of a hospi-
tal-based clinical diagnosis of leptospirosis in 9 provinces
across Thailand. Of 700 suspected cases, 143 (20%) were
confirmed by laboratory testing. Accuracy of clinical diagno-
sis varied from 0% to 50% between the provinces and was
highest during the rainy season. Most confirmed cases
occurred in the north and northeast regions of the country.
L
eptospirosis is an emerging infectious disease in
Thailand (1). Before 1996, the number of cases report-
ed to the Thailand Department of Disease Control (DDC)
was ≈200 per year. Leptospirosis was sporadic and report-
ed mainly in central and southern regions. A marked
change occurred in the decade thereafter, with an increase
from 358 cases in 1996 to a peak of 14,285 cases in 2000.
This was followed by a continual decline to 2,868 cases in
2005 (1). Most cases (90%) throughout this period were
reported in northeast Thailand. Astudy of >600 adults who
sought treatment for fever at 1 hospital on the Thai-
Myanmar border provided further evidence of the impor-
tance of leptospires as a pathogen in this region, with
serologic evidence for leptospirosis found in 17% of the
patients (2). The true extent of the disease is likely consid-
erable in Thailand, which illustrates the need for accurate
epidemiologic tools for its evaluation. An essential part of
this process is understanding the mechanisms of reporting
and their inherent inaccuracies.
Reporting of leptospirosis to the DDC in Thailand is
voluntary. During a review of the national surveillance
system for leptospirosis in 2 northeastern provinces, inter-
viewed physicians said the national case definition was
difficult to understand and apply (3). Investigators con-
cluded that the lack of a standardized case definition for
leptospirosis; the infrequent use of confirmatory laborato-
ry testing; and the inability to link clinical, epidemiologic,
and laboratory data hindered the system’s utility (3). These
results imply that both underreporting and diagnostic inac-
curacy of reported cases may be occurring. We conducted
a prospective multicenter study to define the accuracy of
clinical diagnoses of suspected leptospirosis in Thailand
and to describe the geographic distribution of laboratory-
confirmed cases.
The Study
From March 2003 though November 2004, admitting
physicians in district and provincial hospitals within 9
provinces of Thailand in the north, northeast, central, and
southern regions were invited to recruit patients of all ages
suspected on clinical grounds to have leptospirosis.
Clinical features considered were those specifically
referred to in the national guidelines (e.g., fever, headache,
muscle pain, meningism, conjunctival suffusion, and jaun-
dice), together with hemoptysis, hepatomegaly, diarrhea,
hypotension, and reduced urine output. From each patient,
a 5-mL serum sample was taken to be cultured for
Leptospira,  another 5-mL serum sample was taken for
serologic testing, and a third sample was taken 2 weeks
later for serologic testing. Serum was stored at –80°C until
analysis.
Microscopic agglutination test (MAT) was performed
at the World Health Organization (WHO)/United Nations
Food and Agriculture Organization (FAO)/World Animal
Health Organisation (OIE) Collaborating Center for
Reference and Research on Leptospirosis, Brisbane,
Queensland, Australia (4). A positive MAT was defined as
a single titer of >1:400 or a 4-fold rise in titer between
acute and convalescent phase samples. For Leptospira cul-
ture, 100 µL of whole blood, 500 µL of plasma, and 500
µLof serum were each injected into 3 mLof Ellinghausen,
McCullough, Johnson, and Harris (EMJH) medium and
supplemented with 3% rabbit serum and 0.1% agarose,
then incubated aerobically at room temperature
(25°C–30°C) for 6 months and examined every week for 2
months, every 2 weeks during months 3 and 4, and once a
month during months 5 and 6. Examination was done by
placing 1 drop of culture onto a microscopic glass slide
and viewing by dark-field microscopy at 200× magnifica-
tion. Positive cultures were referred to the WHO/FAO/OIE
Collaborating Center for Reference and Research on
Leptospirosis for identification by using the cross-aggluti-
nation absorption test (4).
Atotal of 700 patients with a clinical diagnosis of lep-
tospirosis were recruited during the study period. All
patients had blood samples collected at the hospital for lep-
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serum samples were obtained during follow-up for 509
(73%) patients.
The median age of patients with suspected leptospiro-
sis was 38 years (range 2–95 years, interquartile range
[IQR] 28–49 years); 504 (72%) were men. The number of
clinically diagnosed leptospirosis cases by month in the
north, northeast, central, and southern regions is shown in
Figure 1. Most cases (597, 85%) were recorded in 4
provinces in the north or northeast (Table). Cases were pre-
dominantly identified during the rainy season
(June–October) in the north and northeast in 2003, with a
second peak in the northeast, but not the north, during the
rainy season of 2004. Little variation occurred over time in
the central and southern regions.
Of the 700 patients who received a clinical diagnosis
of leptospirosis, 143 (20%) received a confirmed diagnosis
of leptospirosis based on Leptospira isolation, MAT test-
ing, or both (Table). The median age of patients with con-
firmed leptospirosis was 35 years (range 10–68 years, IQR
27–45 years); 121 (85%) were men. The diagnosis was
confirmed after isolation of leptospires from 15 (11%)
patients; the geographic distribution is shown in the Table.
The serovars of cultured Leptospira were L. interrogans
serovar (sv.) Autumnalis (7), L. interrogans sv. Bataviae
(2), L. interrogans sv. Pyrogenes (2), L. borgpetersenii sv.
Javanica (1), L. interrogans sv. Hebdomadis (1), L. inter-
rogans sv Grippotyphosa (1), and an unidentified serovar
(1). An additional 128 patients with culture-negative sam-
ples had been exposed to Leptospira as determined by
MAT; results for 96 (75%) were based on a 4-fold rising
titer and for 32 (25%), on a single raised titer of >1:400. 
The geographic distribution of the 143 laboratory-
confirmed cases is summarized in the Table. Most of these
patients (124, 87%) lived in the 4 provinces found in the
north and the northeast. The month of diagnosis for con-
firmed cases is shown in Figure 2; most were during the
rainy season.
The positive predictive accuracy of a clinical diagno-
sis is defined by the number of laboratory-confirmed cases
divided by the number of clinically suspected cases.
Results for each of the 9 provinces are shown in the Table.
When only data from centers that reported at least 10 cases
were used, positive predictive accuracy ranged from 3% to
29%. Positive predictive accuracy by month of study is
shown in Figure 2.
Conclusions
Diagnosing leptospirosis at the point of care is notori-
ously difficult in the tropical setting, where several com-
mon infectious diseases are often hard to differentiate.
Positive predictive accuracy for leptospirosis was highest
during the rainy season, an observation that is likely relat-
ed to the higher disease incidence and pretest probability.
Variability in positive predictive accuracy was seen among
the 3 provinces with the highest number of both suspected
and true cases. The reason for this is unclear but may relate
to perceived risk to the community, local policy, or other
factors.
Diagnosis and Distribution of Leptospirosis, Thailand
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007 125
Figure 1. Cases of clinically suspected leptospirosis by month for
each geographic region, Thailand, March 2003–November 2004.The finding that both clinical and confirmed cases of
leptospirosis were more common in the north and north-
east is consistent with DDC reports. Increased incidence in
this region may have resulted from an event such as an
increase in the rodent population, a natural reservoir for
this pathogen, and a population in which around one third
are positive for Leptospira in northeast Thailand (5).
Alternatively, 1 clone or a small number of bacterial clones
may have become adapted for persistence at greater num-
bers within the natural host or in the environment. These
factors could increase the leptospire count in contaminated
water. It is also possible that 1 clone or a small number of
clones have become adapted for enhanced invasion of the
human host. The most prevalent serovar isolated was L.
interrogans serovar Autumnalis (7/15 [47%] isolates), 6 of
which were from cases in the north or northeast. Further
genomic analysis is required to determine whether clonal-
ity exists among these isolates.
The effect of the low level of accuracy of hospital-
based clinical diagnosis of leptospirosis in rural Thailand
is not known. A common disease in this setting that is eas-
ily confused with leptospirosis is scrub typhus; both dis-
eases would be predicted to respond to doxycycline, an
antimicrobial drug often prescribed for undifferentiated
fever. Further studies are required to define the implica-
tions of our findings and determine whether routine labo-
ratory testing for leptospirosis should be implemented in
Thailand.
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Figure 2. Cases of laboratory-confirmed leptospirosis and positive
predictive accuracy of clinical diagnosis by month, Thailand,
March 2003–November 2004.
Search past issues of EID at www.cdc.gov/eid